Aurdan Capital Management, LLC Abbott Laboratories Transaction History
Aurdan Capital Management, LLC
- $261 Billion
- Q4 2024
A detailed history of Aurdan Capital Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Aurdan Capital Management, LLC holds 47,884 shares of ABT stock, worth $6.46 Million. This represents 2.08% of its overall portfolio holdings.
Number of Shares
47,884Holding current value
$6.46 Million% of portfolio
2.08%Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,361Shares Held
1.36BCall Options Held
10.6MPut Options Held
8.73M-
Vanguard Group Inc Valley Forge, PA169MShares$22.8 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10.4 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$9.17 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.3 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $236B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...